California's Multi-Billion Dollar Plan for Spending on Cell and Gene Therapy Is Nearing Completion
Full Airing Next Week for Public Comment and Review by CIRM Board
Maria Millan, president of the California stem cell agency, will present five-year strategic plan Oct. 19. CIRM photo
The 35 directors of the $12 billion California stem cell agency are scheduled to meet next week for a full day and take up matters ranging from conflicts of interest to results from its latest legislatively required performance audit.
Tha…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.